These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

385 related articles for article (PubMed ID: 25385446)

  • 21. Pharmacokinetics of beta-lactam antibiotics in patients with intra-abdominal disease: a structured review.
    Adnan S; Paterson DL; Lipman J; Kumar S; Li J; Rudd M; Roberts JA
    Surg Infect (Larchmt); 2012 Feb; 13(1):9-17. PubMed ID: 22316144
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical pharmacokinetics of antibacterial drugs in neonates.
    Paap CM; Nahata MC
    Clin Pharmacokinet; 1990 Oct; 19(4):280-318. PubMed ID: 2208898
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacokinetic considerations and dosing strategies of antibiotics in the critically ill patient.
    Shah S; Barton G; Fischer A
    J Intensive Care Soc; 2015 May; 16(2):147-153. PubMed ID: 28979397
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical Determinants of Target Non-Attainment of Linezolid in Plasma and Interstitial Space Fluid: A Pooled Population Pharmacokinetic Analysis with Focus on Critically Ill Patients.
    Minichmayr IK; Schaeftlein A; Kuti JL; Zeitlinger M; Kloft C
    Clin Pharmacokinet; 2017 Jun; 56(6):617-633. PubMed ID: 27753002
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of pharmacokinetics and pharmacodynamics: does the dose matter?
    MacGowan AP
    Clin Infect Dis; 2001 Sep; 33 Suppl 3():S238-9. PubMed ID: 11524725
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The clinical relevance of plasma protein binding changes.
    Roberts JA; Pea F; Lipman J
    Clin Pharmacokinet; 2013 Jan; 52(1):1-8. PubMed ID: 23150213
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Predictability of the effects of race or ethnicity on pharmacokinetics of drugs.
    Johnson JA
    Int J Clin Pharmacol Ther; 2000 Feb; 38(2):53-60. PubMed ID: 10706191
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical relevance of pharmacokinetics and pharmacodynamics in cardiac critical care patients.
    Pea F; Pavan F; Furlanut M
    Clin Pharmacokinet; 2008; 47(7):449-62. PubMed ID: 18563954
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Influence of pharmacokinetics/pharmacodynamics of antibacterials in their dosing regimen selection.
    Scaglione F; Paraboni L
    Expert Rev Anti Infect Ther; 2006 Jun; 4(3):479-90. PubMed ID: 16771624
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Optimal doripenem dosing simulations in critically ill nosocomial pneumonia patients with obesity, augmented renal clearance, and decreased bacterial susceptibility.
    Roberts JA; Lipman J
    Crit Care Med; 2013 Feb; 41(2):489-95. PubMed ID: 23263583
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Potential drug interactions with antibacterials in long-term care facilities analyzed by two interaction checkers.
    Štuhec M; Potočin I; Stepan D; Ušaj L; Petek Šter M; Beović B
    Int J Clin Pharm; 2019 Aug; 41(4):932-938. PubMed ID: 31172409
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Doripenem population pharmacokinetics and dosing requirements for critically ill patients receiving continuous venovenous haemodiafiltration.
    Roberts JA; Udy AA; Bulitta JB; Stuart J; Jarrett P; Starr T; Lassig-Smith M; Roberts NA; Dunlop R; Hayashi Y; Wallis SC; Lipman J
    J Antimicrob Chemother; 2014 Sep; 69(9):2508-16. PubMed ID: 24879665
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antibacterial class is not obviously important in outpatient pneumonia: a meta-analysis.
    Maimon N; Nopmaneejumruslers C; Marras TK
    Eur Respir J; 2008 May; 31(5):1068-76. PubMed ID: 18216053
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of aminoglycoside pharmacokinetics in Asian, Hispanic, and Caucasian patients by using population pharmacokinetic methods.
    Jhee SS; Burm JP; Gill MA
    Antimicrob Agents Chemother; 1994 Sep; 38(9):2073-7. PubMed ID: 7811021
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Economic aspects of antibacterial adverse effects.
    Beringer PM; Wong-Beringer A; Rho JP
    Pharmacoeconomics; 1998 Jan; 13(1 Pt 1):35-49. PubMed ID: 10175984
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Further evidence for interethnic differences in the oral pharmacokinetics of meloxicam.
    Carrasco-Portugal Mdel C; Aguilar-Carrasco JC; Luján M; Reyes-García G; Medina-Santillán R; Flores-Murrieta FJ
    Clin Drug Investig; 2005; 25(5):307-13. PubMed ID: 17532668
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The history of the development and changes of quinolone antibacterial agents].
    Takahashi H; Hayakawa I; Akimoto T
    Yakushigaku Zasshi; 2003; 38(2):161-79. PubMed ID: 15143768
    [TBL] [Abstract][Full Text] [Related]  

  • 38. What is the relevance of fosfomycin pharmacokinetics in the treatment of serious infections in critically ill patients? A systematic review.
    Parker S; Lipman J; Koulenti D; Dimopoulos G; Roberts JA
    Int J Antimicrob Agents; 2013 Oct; 42(4):289-93. PubMed ID: 23880170
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pediatric Obesity: Pharmacokinetic Alterations and Effects on Antimicrobial Dosing.
    Natale S; Bradley J; Nguyen WH; Tran T; Ny P; La K; Vivian E; Le J
    Pharmacotherapy; 2017 Mar; 37(3):361-378. PubMed ID: 28079262
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Systematic Review on Antimicrobial Pharmacokinetic Differences between Asian and Non-Asian Adult Populations.
    Setiawan E; Cotta MO; Roberts JA; Abdul-Aziz MH
    Antibiotics (Basel); 2023 Apr; 12(5):. PubMed ID: 37237706
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.